On Tuesday 24 September 2019, the National Assembly (Assemblée nationale) is debating the bioethics bill in public session. Among the many measures under consideration, the possible reform of the law on medically assisted reproduction (procréation médicalement assistée, PMA) is the subject of heated debate, both in the chamber and in the media.
- Focus: what is medically assisted reproduction?
It is a set of medical techniques enabling an infertile couple to have a child.
Three techniques are currently used:
- artificial insemination – the medical procedure consists of placing sperm in the uterus. This may be done with the partner's sperm or with frozen sperm from an anonymous donor.
- in vitro fertilisation (IVF) – fertilisation takes place in a laboratory, and the (fertilised) embryo is then placed in the woman's uterus.
- embryo donation – the (fertilised) embryo of anonymous donor parents is transferred into the uterus of the woman in the recipient couple. This is intended for couples in which both partners have a fertility problem, or where there is a risk of passing on a genetic disease to the child.
- History of French legislation
The bioethics laws aim, on the one hand, to set the limits of medical intervention on the human body while guaranteeing respect for human dignity and, on the other, to prevent any form of exploitation arising from medicine (organ trafficking, human cloning, etc.).
The 1994 bioethics law was the first in France to address bioethical issues clearly.
It has been revised several times:
- In 2004, with several flagship measures, notably on cloning, the limited opening of embryo research and the prohibition of pre-implantation diagnosis.
- The law of 7 July 2011 notably authorised cross-over organ donation where relatives are incompatible, and ultra-rapid egg freezing (vitrification).
- The law of 6 August 2013 moved from a regime prohibiting embryo research, subject to exemptions, to one of regulated authorisation.
Any proposed bioethics reform must be preceded by a public debate in the form of a national consultation (états généraux) organised by the National Consultative Ethics Committee for Health and Life Sciences (Comité consultatif national d'éthique pour les sciences de la vie et de la santé, CCNE). Following the debate, the committee draws up a report which it presents to the Parliamentary Office for the Evaluation of Scientific and Technological Choices (OPESCT).
The 2011 law was due to be fully reviewed by Parliament within a maximum of 7 years of its entry into force, that is, in 2018.
Accordingly, in September 2018, the CCNE approved the proposed revision of the bioethics laws, subject to a number of reservations.
On 12 June 2019, Prime Minister Édouard Philippe announced, in a general policy statement before the National Assembly, that a bioethics bill including the extension of medically assisted reproduction to single women and female couples would be adopted by the Council of Ministers before the end of July 2019.
It is this bill that is currently being debated in Parliament.
- Current conditions for medically assisted reproduction
In France, medically assisted reproduction (assistance médicale à la procréation) is governed by Articles L2141-124 to L2141-1225 of the Code de la santé publique (French Public Health Code), supplemented by Articles R2141-226 to R2141-1327.
Since 1994, medically assisted reproduction in France has been available to heterosexual couples (married, in a civil partnership (PACS) or cohabiting) of reproductive age who are in one of the following situations:
- The couple, or one of the partners, has a medically diagnosed pathological sterility (or infertility) (fertility assessment).
- One of the partners carries a serious disease that may be passed on to the other partner or to the child.
As a result, a single person in France today cannot access medically assisted reproduction.
Furthermore, Article 311-19 of the Code civil (French Civil Code) provides that, in the case of medically assisted reproduction involving a third-party donor, no legal parentage (filiation) may be established between the donor and the child born as a result.
The consent given by the couple to medically assisted reproduction bars any action to establish or contest parentage, unless it is argued that the child was not born of the medically assisted reproduction or that the consent has ceased to have effect (in the event of death, or of separation during the process).
In March 2018, the administrative courts interpreted “of reproductive age” as an age limit set at the 59th year for a man, while the limit for reimbursement by the French social security system (Sécurité sociale) is set at a woman's 43rd birthday.
- Procedure
The couple must consult a doctor or a medical team specialising in fertility and attend several interviews to establish the couple's motivations and inform them about the procedures.
After the final information interview, the couple has a one-month cooling-off period. This may be extended to 2 months in complex situations.
Once this period has elapsed, the couple must confirm their request for assisted reproduction (AMP) to the doctor in writing.
The national health insurance system (assurance-maladie) covers these procedures in full, up to the mother's 43rd birthday, for a maximum of:
- 6 artificial inseminations,
- 4 in vitro fertilisations.
- The bill's key measures on medically assisted reproduction
From this Tuesday 24 September, the Assembly is debating changes to the conditions for medically assisted reproduction as part of the bioethics bill.
Several points are currently under debate:
- Extending medically assisted reproduction to all women (heterosexual or homosexual, in a couple or single).
- Post-mortem assisted reproduction: the use of stored gametes after death.
- The possibility of storing one's own gametes (reproductive cells), whether by freezing a woman's eggs or a man's sperm. The aim: to allow everyone to have children later in life.
- An end to anonymity for sperm donors. For example, the bill provides that children born from a donation made after the law comes into force may, on reaching adulthood, have access to “non-identifying information” about the donor (age, physical characteristics, etc.), and also to the donor's identity.
- The legal parentage of children born through medically assisted reproduction is another of the controversial points of the bill under consideration.
- Reimbursement of medically assisted reproduction for all women by the social security system is another of the points currently being called into question.
We hope you have found this article useful. The firm is at your disposal both to discuss your personal situation and to work with you to find concrete and effective answers to your problem. Please do not hesitate to contact us.



